Prostate cancer: Screening “modestly” reduces deaths, Cochrane review concludes

Screening with a PSA (prostate specific antigen) blood test reduces prostate cancer deaths by two for every 1000 men screened, though the risk of overdiagnosis remains high, an updated Cochrane review says.1